NCT05937399Completed
Project PLUS Lung Cancer Screening Promotion
Project PLUS- Promoting Lung Cancer Screening Among Screening-Eligible Individuals in Environmentally Burdened Communities Through Enhanced Risk Communication
Source: ClinicalTrials.gov · Last updated 22 Apr 2025
Brief summary (registry, in English)
Project PLUS is a pilot study that aims to develop and obtain preliminary feasibility and efficacy data on an enhanced risk communication approach to promote lung cancer screening (LCS) intentions among screening-eligible individuals from environmentally burdened communities. Project PLUS will combine qualitative interviews to explore subject awareness regarding lung cancer risk and air pollution, barriers to LCS, and perceptions regarding risk communication messaging, develop a health education video, and a between-subjects experiment to compare Data from this pilot will form the basis for enhanced community engagement efforts and subsequent communication research to examine the effectiveness of incorporating the involuntary air pollution risk information in risk communication interventions. The long term goal is to reduce lung cancer burden and disparities among environmentally burdened communities within and outside of Philadelphia.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 34 (actual)
- First submitted
- 29 Jun 2023
- Start date
- 2 Dec 2022
- Primary completion date
- 28 Feb 2023
- Lead sponsor
- Abramson Cancer Center at Penn Medicine
- Diseases
- Lung cancer
- NCT number
- NCT05937399
What you commit to
- Study type: Interventional
- Participants enrolled: 34
- From 2 Dec 2022 to the primary completion date, 28 Feb 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- They are not eligible for lung cancer screening.
- Pilot trial participants are excluded if they:
Other
- Patient interview participants are excluded if:
- Do not meet inclusion criteria;
- Participated in patient interviews.
Criteria the registry did not label
- Patient interview participants will be eligible if they:
- Are ages 50 - 80 years;
- Have a history of at least 20 cigarette pack-years, and who have quit within the past 15 years or are currently smoking;
- Had a primary care visit at Penn Medicine within the last two years (2020-2021);
- Have documented history of lung cancer screening or lung cancer
- Are residing in one of 10 eligible zip codes;
- Are English-speaking;
- Are able to view the study videos;
- Are able to participate in a video-conference interview using a HIPAA-compliant platform or able to participate in an interview over the phone.
- Pilot trial participants will be eligible if they:
- Are ages 50 - 80 years;
- Are documented history of at least 20 cigarette pack-years, and who have quit within the past 15 years or are currently smoking;
- Have no documented history of lung cancer screening or lung cancer;
- Did not participate in patient interviews;
- Had a primary care visit at Penn Medicine within the last two years (2020-2022);
- Are residing in one of 10 eligible zip codes;
- Are English-speaking;
- Are able to view the study videos and complete an online survey.
Age in the registry: 50 years to 80 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Pennsylvania Coordinator of this site? Confirm its status | Philadelphia | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.